ABSTRACT -Diethylstilbestrol (DES) was administered subcutaneously at 1.5 or 15 µg/kg/day (DES 1.5 group, DES 15 group) to pregnant SD rats daily on days 7-21 of gestation to investigate its effects on the development and functions of the reproductive system and thyroid gland in their offspring. Of the 11 pregnant rats in the DES 15 group, only one delivered a live pup. Rat pups in the DES 1.5 group were autopsied at 1, 3, or 6 weeks after birth. In the DES 1.5 group, the plasma T 4 concentrations at all weeks of age at autopsy were significantly increased, the TSH concentration at 6 weeks of age was also significantly increased, and the height of thyroid follicular epithelial cells was increased at 3 weeks. The testosterone concentration in the DES 1.5 group at 6 weeks was significantly decreased and the plasma LH concentration was increased. The DES treatment increased the plasma FSH concentration in female pups at 3 weeks, increased the percentages of primary and secondary ovarian follicles, and decreased the percentage of primordial follicles, but did not influence the timing of the vaginal opening or the onset of the estrous cycle. These observations indicate that prenatally administered DES increases thyroid function, and has an inhibitory effect on testicular function and a promoting effect on female reproductive function.
INTRODUCTION
In humans, intrauterine exposure to diethylstilbestrol (DES), a potent synthetic and nonsteroidal estrogen that has been administered during pregnancy to prevent miscarriages, leads to an increased incidence of reproductive tract abnormalities. The effects of prenatal DES exposure in so-called DES-daughters, such as an increased risk of genital carcinoma, have been well documented (Bornstein et al., 1988) . The sons born from DES-treated pregnancies have also showed an increased incidence of genital tract abnormalities, including epididymal cysts, cryptorchidism, and the presence of Mullerian duct remnants (Gill et al., 1976; Whitehead and Leiter, 1981) . This indicates that DES has an effect on male sex differentiation. To study the prenatal effects of DES on the developing genital tract in an animal model, McLachlan et al. (1975) injected DES daily into pregnant mice during the phase of growth and differentiation of the fetal reproductive tract. Observations on the male offspring of these DEStreated mice indicated that the developing reproductive tract of the fetus is sensitive to DES exposure. Subsequent work with laboratory animals, primarily rodents, established that prenatal or early postnatal exposure to DES induced numerous structural and functional abnormalities in estrogen-responsive tissues (Marselos and Tomatis, 1993) . In a number of studies, androgendependent reproduction disorders with decreased androgen levels have been reported in perinatally or neonatally DES-treated rats (Stillman, 1982; Arai et al., 1983; Sharpe et al., 1998 ; Fisher et al., 1999 ; Haavisto et al., 2001) . In female rats following in utero DES exposure, mammary and vaginal tumors, but not uterine tumors, were observed (Rothschild et al., 1987; Baggs et al., 1991) . Rats are generally highly susceptible to the abortifacient and teratogenic effects of DES (Marselos and Tomatis, 1993) . As described above, numerous studies have used DES, but mostly in high doses ranging from 10 to 300 µg/kg , to induce gross adverse changes in the developing male reproductive tract.
It is well known that prenatal or neonatal exposure to PCB, an endocrine disruptor with estrogenic activity, results in a postnatal decrease in plasma thyroid hormone (T 4 ) levels. Low levels of T 4 are thought to have an inhibitory effect on spermatogenesis. It would be very interesting to know the effects of DES on thyroid function, but no studies have investigated this question. In this study, we examined the effects of relatively low doses of DES on the development and function of the reproductive system and the thyroid gland in offspring of rats given DES during pregnancy.
MATERIALS AND METHODS

Animals and treatments
Sprague-Dawley rats (Japan SLC) were given a commercial diet (CE-2, CLEA , Tokyo, Japan) and water, both ad libitum. Females were mated with males overnight and were examined the next morning for the presence of sperm in the vaginal smear. The day on which sperm was detected was counted as day 0 of gestation. Pregnant rats were housed individually and maintained 12/12 hr light-dark cycle at room temperature of 21 ± 2°C and humidity of 55 ± 5%. Pregnant rats were divided into three groups. The rats in each group were treated daily subcutaneously with DES (Sigma Chemical Co., St.Louis, MO,USA) 15 µg/kg/day (DES 15 group) or 1.5 µg/kg/day (DES 1.5 group) dissolved in corn oil (tocopherol stripped, ICN Biomedicals Inc.,USA), or corn oil alone (control group) on days 7-21 of gestation. The volume of a single dose ranged from 0.2-0.4 ml. The high dose level of DES in this study was determined based on the findings of a previous study (Boylan,1978) .
Four days after birth, pups were controlled to 4 males and 4 females in each litter. There were 10 litters per group. The pups were kept with their natural mothers until weaning on day 21. Rats were autopsied at postnatal weeks 1, 3 and 6, and the thyroid gland, adrenal gland, testis, epididymis and ovary were dissected out and weighed. In general, pregnant rats delivered on the afternoon of day 21 of gestation.
Histological preparations
The dissected thyroid gland and ovary were fixed in Bouin's solution, dehydrated in a graded series of ethanol, embedded in paraplast and sectioned serially at 5 µm.
Morphometrical analysis
The thyroid sections were stained with periodic acid-Schiff (PAS) and hematoxylin. The average diameter of follicles and the average height of he follicular cells were determined as described by Eguchi and Morikawa (1966) .
The uterus and vagina, including the pudendal cleft and external urethral orifice, were carefully dissected out together, fixed with pins onto hard thick paper, and transferred into Bouin's solution. One day later, the width and length of uterine horn and the length of the vagina were measured with a micrometer set in a dissecting microscope. For histological observation, a transverse section of the uterine horn and a sagittal section of the vagina were made and stained with the Masson Trichrome method.
Classification of follicles in ovary
Serial ovary sections were stained with hematoxylin and eosin and examined by light microscopy. All follicles were classified into primordial follicles, primary follicles, secondary follicles and vesicular follicles, and the number of each type was counted. To prevent duplicate counting, the nucleolus was used as the identifying landmark.
Hormonal measurement
A blood sample was collected from the heart of each animal prior to necrospy. The blood samples were centrifuged at 4°C, and the plasma stored at −80°C until assay. ] assay system (Amersham Pharmacia Biotech, USA). The sensitivity was determined to be 4 ng/dl, 0.3 µg/dl and 0.78 ng/ml, respectively. The concentrations of pituitary hormones, LH, FSH and TSH, were measured by using a rat luteinizing hormone enzyme immunoassay system, a rat follicle stimulating hormone enzyme immunoassay system and a rat thyroid stimulating hormone enzyme immunoassay system (Amersham Pharmacia Biotech, USA), respectively. The sensitivity was determined to be 0.1 ng/ml, 8.66 ng/ml and 0.6 ng/ml, Vol. 28 No. 5 respectively.
Vaginal opening and estrous cyclicity
Each female offspring was examined daily for vaginal opening (VO) beginning on postnatal day 21. On the day that VO was first detected, the age (postnatal days), was recorded. Daily vaginal smear was collected from the day following VO and then daily until the end of the study.
Statistical analysis
The mean values and standard errors were calculated for the organ weights, hormone concentrations, and morphometrical parameters. Statistical analyses of data were made by means of Student's t-test (Steel and Torrie, 1980) . Values of p<0.05 were considered significant.
RESULTS
General observations
All 10 pregnant rats in the control group delivered pups, and 9 suckled pups. In the DES 1.5 group, all 10 pregnant rats delivered pups, but 4 mothers abandoned pup rearing, and only 6 suckled pups. In the DES 15 group, all of 11 pregnant rats used began to bleed from the second trimester, and only 1 delivered, and this rat suckled only 1 pup. The administration of DES tended to prolong pregnancy. Thus, only the data on the control and DES 1.5 groups are shown below. Tables 1a and 1b show the body weight and the weight of various organs of pups in each group at autopsy. The administration of 1.5 µg/kg/day of DES did not change the weight of the body, thyroid gland, adrenal gland, testes, or ovaries, but significantly decreased the relative weight of the thyroid gland and increased the relative weight of the testis in the DES 1.5 group at 3 weeks after birth, compared with the control group. At 6 weeks of age, the weight of the epididymis and the relative weight of the epididymis were significantly decreased in the DES 1.5 group.
Effects on thyroid gland
The concentrations of plasma thyroid hormone (T 4 ) and TSH, the morphologically measured size of the thyroid follicles and the height of follicular epithelial cells in the pups, are shown in Table 2 . The T 4 concentrations in the DES 1.5 group were significantly increased on all days of autopsy. The plasma TSH concentration in the DES 1.5 group was significantly increased at 6 weeks after birth. In addition, the diameter of follicles in the DES 1.5 group at 1 week after birth was significantly decreased, and the height of follicular epithelial cells at 3 weeks after birth was significantly increased. Table 3 shows the results of the determination of plasma hormone concentrations in pups at 3 and 6 weeks after birth. The plasma testosterone concentrations in pups at 3 weeks after birth were below the detection limits. At 6 weeks after birth, the plasma testosterone concentration in the DES 1.5 group was significantly decreased. The plasma FSH concentrations in the male pups in the DES 1.5 group at 3 and 6 weeks after birth were significantly increased, and the plasma LH levels in the male pups in the DES 1.5 group at 3 and 6 weeks were increased, but not significantly.
Changes in plasma hormone concentrations
The plasma FSH concentration in female pups at 3 weeks after birth was significantly increased.
Effects on the maturation of ovarian follicles
All follicles in the ovary were observed and classified into 4 types according to the degree of maturation, which was expressed as percent of the total number of follicles (Table 4 ). The percentages of the primary and secondary follicles in the ovary in the DES 1.5 group at 3 weeks after birth were increased, and the percentage of the primordial follicles was decreased. At 6 weeks after birth, no difference was noted in the degree of follicular maturation between the two groups.
Effects on the development of the female reproductive organs
The timing of the vaginal opening in the DES 1.5 group did not differ from that in the control group. The administration of DES did not influence the onset of the first estrus, as determined by vaginal smear examination. Measurement of the diameter and length of the uterine horn as parameters of uterine development showed that the diameters of the left and right uterine horns in the DES-administered group were significantly increased (Table 5) .
To investigate whether the administration of DES is involved in the development of the urethra and vagina, sections were prepared so that the same section contained the large intestine, uterus, and urethra (Photo 1). At 1 week after birth, the vagina was located between the urethra and rectum, being completely separated from the urethra. Although the sinovaginal bulb (the developing portion of the vagina) communicated with the body surface (the epidermal portion), the vaginal lumen was not formed yet; that is, the vagina had not opened. These observations were similar in the control and DES-administered groups. At 3 weeks after birth, the vaginal lumen began to be formed in the sinovaginal bulb, but had not reached the body surface.
There was no difference in the degree of urogenital development between the DES 1.5 group and control groups. Since the vaginal opening was formed about 35 days after birth in this study, it had already been formed when female offspring were autopsied at 6 weeks after birth. Histologically, the vaginal epithe- Table 1a . Effects of prenatal exposure to DES on body weight and the weight of the thyroid gland and adrenal gland. Boylan (1978) administered various doses of DES s.c. to SD rats, then determined the delivery rates and survival rates of pups, and found that the administration of 60 µg of DES to 11 rats on days 10 and 13 of gestation resulted in 7 pregnant rats delivering pups, while the administration of 120 µg of DES to 34 rats on days 15,17 and 19 of gestation resulted in 21 pregnant rats delivering pups. These results suggest that the administration of DES in the second trimester greatly influences delivery. In our study to investigate the prenatal effects of DES, we determined the high dose level of DES (15 µg/kg/day) considering Boylan's results regarding administration of DES on days 10 and 13 of gestation. As expected, we found that the administration of 15 µg/kg/day of DES greatly influenced delivery, and that the DES dose at 1.5 µg/kg/day was appropriate for the chief objective of this study.
DISCUSSION
In this study, the plasma T 4 levels in the DES 1.5 group were increased at all weeks of age. In the only report showing that the administration of DES changes thyroid hormone levels irrespective of the timing of administration, Kim et al. (2002) found that, among several substances with hormonal activity given to female rats from postnatal day 20 for 20 days, DES administration increased T 3 , and testosterone adminis- Table 2 . Effects of prenatal exposure to DES on plasma T 4 concentrations and histological parameters of thyroid glands. tration deceased T 4 . Thyroxine-binding globulin (TBG), a protein that generally transports T 4 , is synthesized in the liver; the administration of estrogen increases the amount of TGB synthesized, while androgen and glucocorticoid decrease it; and the levels of TBG and total T 4 have parallel dynamics (Emerson et al., 1990) . Therefore, it is thought that an increase in TBG is associated with an increase in total T 4 . Thus, we speculate that the increase in total plasma T 4 concentrations observed in this study was due to transplacental transfer to fetuses of DES administered to pregnant rats, which increased the synthesis of fetal TBG, and that this effect persisted after birth. TSH was significantly increased in the DES-administered group only at 6 weeks after birth, compared with that in the control group. In addition, morphometrical analysis of the thyroid gland as a functional indicator (Yamamoto et al., 1986) showed that the height of follicular epithelial cells was increased in the DES-administered group at 3 weeks after birth. These results suggest that transplacental exposure to DES activates the pituitary-thyroid system in pups. Exogenous estrogen increases total RNA levels in the anterior pituitary (Zyu et al., 1997) , and controls the expression of anterior pituitary TRH-degrading coenzyme (Schomburg and Bauer, 1997) . Therefore, we speculate that the observed DESinduced increase in plasma T 4 concentrations involved not only an increase of TBG but also effects on the pituitary. We are also considering investigating changes in T 3 concentrations in the future.
The administration of DES to newborn pups permanently suppresses the testosterone levels, Sertoli cell numbers, spermatogenesis (Sharpe et al., 1998; Atanassova et al., 1999) , and the expression of estrogen receptor-α in the epididymis (Atanassova et al., 2001) . In this study, the administration of DES to pregnant rats greatly decreased plasma testosterone concentrations in pups at 6 weeks after birth. It has been demonstrated that exogenous estrogen inhibits the androgen-synthesizing system in Leydig cells. There is a report that the intraperitoneal administration of high doses of DES (100 or 500 µg/kg) to pregnant rats on days 11 and 15 of pregnancy decreases the level of expression of mRNA for the testosterone-synthesizing enzyme P450 17α in fetal Leydig cells (Majdic et al., 1996) . Furthermore, the addition of estrogen to cultured fetal rat Leydig cells in vitro inhibits the production of androgen (Moger, 1980) . During pregnancy, mothers secrete large amounts of estrogen, which cross the placenta and circulate in the blood of fetuses. However, in rodents, α-fetoprotein synthesized in the fetal liver binds to maternally derived estrogen and inhibits the action of estrogen on male fetuses (Vannier and Raynaud, 1975) . Since DES does not bind to α-fetoprotein (Savu et al., 1979) , DES administered to pregnant rats occurs in a free state in fetuses, and may inhibit the androgen-synthesizing system in the Leydig cells of the fetal testis. Table 4 . Effects of prenatal exposure to DES on follicular maturation in ovary. Table 5 . Effects of prenatal exposure to DES on the size of the uterine horn in 6-week-old female offspring.
Group
Age No. Primordial Primary Secondary Vesicular follicles follicles follicles follicles % % % % Control 3 wks 6 78.1 ± 1.4 11.0 ± 0.5 5.5 ± 0.5 5.5 ± 0.7 DES 1.5 6 68.3 ± 2.5 * 14.8 ± 1.8 * 9.3 ± 0.7 * 7.7 ± 0.9 Control 6 wks 5 84.5 ± 0.2 7.0 ± 0.4 5.7 ± 0.5 1.8 ± 0.2 DES 1.5 6 83.1 ± 1.5 9.0 ± 0.4 5.3 ± 0.6 2.6 ± 0. In this study, DES decreased testosterone concentrations and LH concentrations. Since the negative feedback mechanism of the rat pituitary-testis system normally starts working at 19.5 days of fetal age (Habert and Picon, 1982; Pakarinen et al., 1994) , the pituitary responds to decreased testosterone concentrations by increasing LH concentrations. In the DESadministered group observed at 6 weeks after birth, the pituitary responded to the decreased testosterone levels, suggesting that the feedback mechanism of the pituitary-testis system was functioning normally.
The amount of testosterone secretion decreased, and FSH concentrations increased when LH concentrations were expected to increase. FSH acts on Sertoli cells to promote the synthesis of the androgen-binding protein and the transport of androgen to seminiferous tubules. LH promotes the synthesis of testosterone by Leydig cells, on which FSH simultaneously acts to increase the number of cell-surface LH receptors. It is possible that, in this study, the pituitary responded to decreased testosterone by secreting a larger amount of FSH, consequently increasing LH receptors on Leydig cells.
In this study, in the ovaries of pups in the DESadministered group at 3 weeks after birth, the percentages of primary and secondary ovarian follicles were increased, and the percentage of primordial ovarian follicles was decreased, while plasma FSH concentrations were increased. These results suggest that the administration of DES exerts a promoting effect on the maturation of ovarian follicles. Estrogen paracrinely promotes the maturation of ovarian follicles (Wu et al., 1992 (Wu et al., , 1993 . Estrogen and FSH promote the maturation of ovarian follicles. ER α has been demonstrated immunohistochemically in ovarian stromal cells at 1 day after birth, and ER β in those on day 5 after birth, suggesting that estrogen promotes the maturation of ovarian follicles through the ER (Sar and Welsch, 1999) . Since rat fetuses do not synthesize estrogen, which is first detected in the ovaries of newborn pups (Weniger, 1993; Weniger et al., 1993) , it seems reasonable as explained physiologically that ER is first expressed in the ovary after birth. However, in this study, free DES, which does not bind to α-fetoprotein, was present in the fetal period; therefore, the results obtained suggest that DES hastened the expression of ER in the ovary, although the expression of ER in the ovary in the fetal period has not been demonstrated. Since DES was circulating in female fetuses, it may have promoted the expression of ER in the ovary. At 23 days after birth, α-fetoprotein decreases sharply, and free estrogen increases sharply. At 21 days after birth, estrogen starts to exert a negative feedback effect on the release of FSH (Raynaud et al., 1971; Puig-Duran et al., 1979) . The positive feedback mechanism remains incomplete until 16 days after birth, and the reactivity is thought to increase thereafter as the days of age increases (Andrews et al., 1981) . It appears that DES does not influence the higher center, the hypothalamus-pituitary-ovary-system, of female rats, but exerts a promoting effect on the development of ovarian function, similar to the effect on male rats.
The administration of DES at 6 to 20 days of gestation makes the endometrium of female pups edematous (Piersma et al., 2002) . This is considered to be due to the estrogenic activity of DES, and is reminiscent of the effect observed in daughters born when DES was used as a drug for pregnant women (Herbst et al., 1971) . The ovarian hormones estrogen and prolactin play important roles in the cell division, differentiation, and functional development of rat Müllerian ducts, and act through estrogen receptors (ER) and prolactin receptors (PR). Recently, it has been shown that ERα and PR are present in the epithelial cells and mesenchymal tissue in the middle region (differentiating to become the uterus) and the caudal region (differentiating to become the upper portion of the vagina) of rat fetal Müllerian ducts, and that the administration of DES to pregnant rats enhances the expression of PR in the mesenchymal tissue of the middle and caudal regions in their fetuses (Okada et al., 2002) . Therefore, we speculate that the observed increase in the outer diameter of the uterus resulted from the promotion of the development of the lamina propria of the endometrium through mesenchymal PR. Moreover, plasma FSH concentrations tended to increase at 3 weeks after birth, suggesting that FSH contributes to promoting the DES-induced development of the lamina propria of the endometrium. Finally, the administration of DES at 1.5 µg/kg/day did not influence the timing of formation of the vaginal opening or the differentiation of the vagina, possibly because DES did not influence the expression of PR in the epithelial cells in the caudal region of fetal Müllerian ducts (Okada et al., 2002) .
The present data suggest that the administration of a low dose of DES (1.5 µg/kg/day) irreversibly inhibits thyroid function and testicular endocrine function, and that it reversibly promotes follicular ripening in the ovary. In addition, the threshold at which DES exhibits inhibitory effects in vivo may be lower than 1.5 µg/kg/day, which was used in this experiment.
However, an accurate value cannot be obtained from the data obtained in this experiment alone. In the future, an experiment regarding the threshold of the DES dose should be conducted.
